SCHEMBL22326121

SCHEMBL22326121

COc1cc(C(c2ccc(O)c(OC)c2)C(F)(F)F)ccc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.57
CYP3A4 P08684 1/20 0.57
BLM P54132 2/20 0.56
NFKB1 P19838 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
PMP22 Q01453 1/20 0.54
MAOB P27338 1/20 0.52
BCHE P06276 2/20 0.50
TYR P14679 2/20 0.50
ACHE P22303 2/20 0.50
SLC22A3 O75751 1/20 0.50
CYP19A1 P11511 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
GAA P10253 1/20 0.47
FOS P01100 1/20 0.46
TTR P02766 1/20 0.46
JUN P05412 1/20 0.46
NR3C1 P04150 1/20 0.46
HSD17B1 P14061 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28507984 0.87 TSHR (0.56) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL7128355 0.86 TSHR (0.58) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL22208556 0.81 TSHR (0.61) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL20563424 0.80 TSHR (0.65) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL1595549 0.80 TSHR (0.65) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL30343472 0.80 TSHR (0.65) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL21852873 0.79 TSHR (0.62) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL29625307 0.79 TSHR (0.62) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL7901872 0.79 TSHR (0.68) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL2411502 0.79 TSHR (0.62) TSHRCYP3A4BLMNFKB1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020162408-A1 METHOD FOR PRODUCING 1,1,1-TRIFLUORO-2,2-BISARYLETHANE, AND 1,1,1-TRIFLUORO-2,2-BISARYLETHANE セントラル硝子株式会社 2020-08-13 WO claimed
US-12435185-B2 Method for producing 1,1,1-trifluoro-2,2-bisarylethane, and 1,1,1-trifluoro-2,2-bisarylethane CENTRAL GLASS COMPANY, LIMITED (JP) 2025-10-07 US disclosed
US-20220106444-A1 Method for Producing 1,1,1-Trifluoro-2,2-Bisarylethane, and 1,1,1-Trifluoro-2,2-Bisarylethane CENTRAL GLASS COMPANY, LIMITED (JP) 2022-04-07 US disclosed
WO-2020162408-A1 METHOD FOR PRODUCING 1,1,1-TRIFLUORO-2,2-BISARYLETHANE, AND 1,1,1-TRIFLUORO-2,2-BISARYLETHANE セントラル硝子株式会社 2020-08-13 WO disclosed
WO-2020162408-A1 METHOD FOR PRODUCING 1,1,1-TRIFLUORO-2,2-BISARYLETHANE, AND 1,1,1-TRIFLUORO-2,2-BISARYLETHANE セントラル硝子株式会社 2020-08-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220106444-A1 Method for Producing 1,1,1-Trifluoro-2,2-Bisarylethane, and 1,1,1-Trifluoro-2,2-Bisarylethane NAF1, FXR1, AFF1 TSHR 1232/4885CYP3A4 1051/4885BLM 614/4885
US-12435185-B2 Method for producing 1,1,1-trifluoro-2,2-bisarylethane, and 1,1,1-trifluoro-2,2-bisarylethane NAF1, FXR1, AFF1 TSHR 1232/4885CYP3A4 1051/4885BLM 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.